Dsatinib 50mg Tablet

About

Dasatinib is a potent, orally bioavailable tyrosine kinase inhibitor (TKI) that targets multiple tyrosine kinases, including BCR-ABL, SRC family kinases, c-KIT, EPHA2, and PDGFRβ. It is primarily used in the treatment of chronic myeloid leukemia (CML) and Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL). By inhibiting these kinases, dasatinib interferes with the signaling pathways crucial for the proliferation and survival of cancer cells, particularly those driven by the BCR-ABL fusion protein.

Its mechanism of action allows it to overcome resistance to imatinib, another TKI, making it a valuable second-line or even first-line option in specific patient populations. The drug's broad kinase inhibition profile contributes to its efficacy in various stages of CML, including chronic, accelerated, and blast phases, as well as in Ph+ ALL.

Uses

• Treatment of chronic myeloid leukemia (CML) in adults.
• Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia (Ph+ ALL).
• Used in patients resistant or intolerant to prior therapy, including imatinib.
• First-line treatment for newly diagnosed CML in chronic phase.

Directions For Use

Take this medication orally once daily, with or without food, as directed by your physician. Do not crush, cut, or chew the tablet.

Benefits

• Effective in treating CML and Ph+ ALL.
• Can overcome resistance to other TKIs like imatinib.
• Available as an oral tablet for convenient administration.
• Targets multiple key oncogenic kinases.
• Demonstrates efficacy across various phases of CML.
• Improves progression-free and overall survival in eligible patients.

Side Effects

• Fluid retention (pleural effusion, peripheral edema)
• Myelosuppression (anemia, neutropenia, thrombocytopenia)
• Diarrhea
• Nausea
• Headache
• Fatigue
• Rash
• Dyspnea
• Hemorrhage
• Cardiac dysfunction (QT prolongation)
• Hypertension
• Musculoskeletal pain

Safety Measures

• Alcohol - Avoid or limit alcohol consumption as it may exacerbate certain side effects or interact with the medication.
• Pregnancy - Dasatinib is contraindicated in pregnancy due to potential fetal harm. Effective contraception is required for women of childbearing potential.
• Breastfeeding - Breastfeeding is not recommended during treatment with dasatinib and for a period after the last dose, due to potential excretion into breast milk and harm to the infant.
• Liver - Use with caution in patients with hepatic impairment; dose adjustments may be necessary. Monitor liver function tests regularly.
• Kidney - Use with caution in patients with renal impairment. No specific dose adjustment is typically required for mild to moderate impairment, but close monitoring is advised.
• Lung - Monitor for pulmonary hypertension and pleural effusion, which are known side effects. Seek medical attention for new or worsening respiratory symptoms.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.